May 24, 2024 · Form 4 insider transaction
ASELAGE STEVE bought 2,500 shares of BioCryst Pharmaceuticals, Inc. at $6.40 per share, a transaction worth $16.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.